Cargando…
Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn’t?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170762/ https://www.ncbi.nlm.nih.gov/pubmed/34400936 http://dx.doi.org/10.22037/ijpr.2021.115076.15183 |
_version_ | 1783702306208874496 |
---|---|
author | Eslamian, Laleh Ahmadi, Marjan Ahmadi, Mahnaz |
author_facet | Eslamian, Laleh Ahmadi, Marjan Ahmadi, Mahnaz |
author_sort | Eslamian, Laleh |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8170762 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-81707622021-08-15 Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn’t? Eslamian, Laleh Ahmadi, Marjan Ahmadi, Mahnaz Iran J Pharm Res Letter to Editor Shaheed Beheshti University of Medical Sciences 2021 /pmc/articles/PMC8170762/ /pubmed/34400936 http://dx.doi.org/10.22037/ijpr.2021.115076.15183 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to Editor Eslamian, Laleh Ahmadi, Marjan Ahmadi, Mahnaz Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn’t? |
title | Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn’t? |
title_full | Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn’t? |
title_fullStr | Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn’t? |
title_full_unstemmed | Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn’t? |
title_short | Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn’t? |
title_sort | prescribing aspirin for preeclampsia prevention in pregnant women during covid-19: should or shouldn’t? |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170762/ https://www.ncbi.nlm.nih.gov/pubmed/34400936 http://dx.doi.org/10.22037/ijpr.2021.115076.15183 |
work_keys_str_mv | AT eslamianlaleh prescribingaspirinforpreeclampsiapreventioninpregnantwomenduringcovid19shouldorshouldnt AT ahmadimarjan prescribingaspirinforpreeclampsiapreventioninpregnantwomenduringcovid19shouldorshouldnt AT ahmadimahnaz prescribingaspirinforpreeclampsiapreventioninpregnantwomenduringcovid19shouldorshouldnt |